These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9539332)

  • 1. P450 enzymes and Parkinson's disease: the story so far.
    Riedl AG; Watts PM; Jenner P; Marsden CD
    Mov Disord; 1998 Mar; 13(2):212-20. PubMed ID: 9539332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
    Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
    Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the molecular mechanism of human cytochrome P450 and genetic polymorphism of drug oxidative metabolizing enzyme].
    Zhao L; Lou YQ
    Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):35-40. PubMed ID: 10921075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in Parkinson's disease.
    Checkoway H; Farin FM; Costa-Mallen P; Kirchner SC; Costa LG
    Neurotoxicology; 1998; 19(4-5):635-43. PubMed ID: 9745923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.
    Kurth MC; Kurth JH
    Am J Med Genet; 1993 Oct; 48(3):166-8. PubMed ID: 8291573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
    Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
    Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease.
    Pang CP; Zhang J; Woo J; Chan D; Law LK; Tong SF; Kwok T; Kay R
    Mov Disord; 1998 May; 13(3):529-32. PubMed ID: 9613747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic polymorphisms of cytochrome P450 1A1 and susceptibility of early-onset Parkinson's disease].
    Liu P; Liu Z; Shao M; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):283-5. PubMed ID: 11484167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.
    Landi MT; Ceroni M; Martignoni E; Bertazzi PA; Caporaso NE; Nappi G
    Adv Neurol; 1996; 69():61-72. PubMed ID: 8615186
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB; Daniel SE; Blunt SB
    Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between the debrisoquine hydroxylase gene polymorphism and the genetic susceptibility of Parkinson's disease].
    Tao E; Liu Z; Chen B; Pan X; Shao M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):281-3. PubMed ID: 9758873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of the entire mitochondrial genome in Parkinson's disease.
    Vives-Bauza C; Andreu AL; Manfredi G; Beal MF; Janetzky B; Gruenewald TH; Lin MT
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1593-601. PubMed ID: 11820805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
    Mann A; Miksys SL; Gaedigk A; Kish SJ; Mash DC; Tyndale RF
    Neurobiol Aging; 2012 Sep; 33(9):2160-71. PubMed ID: 21958961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease.
    Deng Y; Newman B; Dunne MP; Silburn PA; Mellick GD
    Neurosci Lett; 2004 Aug; 366(3):326-31. PubMed ID: 15288444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.